Kraig Biocraft Laboratories, Inc.
KBLB· OTC
Filed May 12, 2023 · 10-Q · 42 days after period end · 0001493152-23-016671
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Net Income | -$566.78K | -$1.05M | -$940.66K | -$3.05M |
| EPS Diluted | $0.00 | — | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR
ended Mar 31, 2023 · filed May 12, 2023 · 42 d after period end